Mir Hashim - Net Worth and Insider Trading

Mir Hashim Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mir Hashim owns 1 companies in total, including Rani Therapeutics Holdings Inc (RANI) .

Click here to see the complete history of Mir Hashim’s form 4 insider trades.

Insider Ownership Summary of Mir Hashim

Ticker	Comapny	Transaction Date	Type of Owner
RANI	Rani Therapeutics Holdings Inc	2023-03-22	Chief Scientific Officer

Mir Hashim Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mir Hashim Ownership Network

Ownership Network List of Mir Hashim

No Data

Ownership Network Relation of Mir Hashim

Mir Hashim Owned Company Details

What does Rani Therapeutics Holdings Inc do?

Who are the key executives at Rani Therapeutics Holdings Inc?

Mir Hashim is the Chief Scientific Officer of Rani Therapeutics Holdings Inc. Other key executives at Rani Therapeutics Holdings Inc include director & CEO Talat Imran , 10 percent owner Quiroga Cortes Isidoro Alfonso , and 10 percent owner South Cone Investments Limited Partnership .

Rani Therapeutics Holdings Inc (RANI) Insider Trades Summary

Over the past 18 months, Mir Hashim made no insider transaction in Rani Therapeutics Holdings Inc (RANI). Other recent insider transactions involving Rani Therapeutics Holdings Inc (RANI) include a net purchase of 5,345,112 shares made by South Cone Investments Limited Partnership , a net purchase of 40,000 shares made by Talat Imran , and a net sale of 5,265,165 shares made by Quiroga Cortes Isidoro Alfonso .

In summary, during the past 3 months, insiders sold 0 shares of Rani Therapeutics Holdings Inc (RANI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,265,165 shares of Rani Therapeutics Holdings Inc (RANI) were sold and 5,436,112 shares were bought by its insiders, resulting in a net purchase of 170,947 shares.

Rani Therapeutics Holdings Inc (RANI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rani Therapeutics Holdings Inc Insider Transactions

No Available Data

Mir Hashim Mailing Address

Above is the net worth, insider trading, and ownership report for Mir Hashim. You might contact Mir Hashim via mailing address: C/o Rani Therapeutics Holdings, Inc., 2051 Ringwood Avenue, San Jose Ca 95131.

Discussions on Mir Hashim

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.